{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:41:40Z","timestamp":1793065300213,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ejogrb.2009.11.001","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T09:34:26Z","timestamp":1260178466000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): A Phase III trial"],"prefix":"10.1016","volume":"149","author":[{"given":"Santiago","family":"Palacios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Parke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Machlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"R\u00f6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2009.11.001_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"Suppl. 2","key":"10.1016\/j.ejogrb.2009.11.001_bib2","first-page":"9","article-title":"The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg","volume":"4","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.ejogrb.2009.11.001_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception","volume":"21","year":"1980","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.ejogrb.2009.11.001_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-0528.1979.tb11276.x","article-title":"Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17beta-oestradiol","volume":"86","author":"Astedt","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2009.11.001_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0010-7824(96)00201-6","article-title":"The pharmacodynamic effects of an oral contraceptive containing 3mg micronized 17beta-estradiol and 0.150mg desogestrel for 21 days, followed by 0.030mg desogestrel only for 7 days","volume":"54","author":"Csemiczky","year":"1996","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ejogrb.2009.11.001_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"issue":"4\u20136","key":"10.1016\/j.ejogrb.2009.11.001_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.ejogrb.2009.11.001_bib8","first-page":"183","article-title":"Efficacy and tolerability of a combined oral contraceptive containing 17beta-estradiol and desogestrel","volume":"1","author":"Kivinen","year":"1996","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.ejogrb.2009.11.001_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00016348709015732","article-title":"Ovulation inhibition with 17beta-estradiol cyclo-octyl acetate and desogestrel","volume":"66","author":"Schubert","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8140","key":"10.1016\/j.ejogrb.2009.11.001_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91525-3","article-title":"Natural oestrogens for oral contraception","volume":"2","author":"Serup","year":"1979","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejogrb.2009.11.001_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)56210-4","article-title":"Ovulation inhibition with a combined oral contraceptive containing 1mg micronized 17beta-estradiol","volume":"60","author":"Wenzl","year":"1993","journal-title":"Fertil Steril"},{"issue":"Suppl. 1","key":"10.1016\/j.ejogrb.2009.11.001_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01849449","article-title":"Oral contraceptives and cycle control: a critical review of the literature","volume":"8","author":"Rosenberg","year":"1992","journal-title":"Adv Contracept"},{"issue":"3","key":"10.1016\/j.ejogrb.2009.11.001_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2008.05.004","article-title":"Ovulation inhibition with four variations of a four-phasic estradiol valerate\/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies","volume":"78","author":"Endrikat","year":"2008","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.ejogrb.2009.11.001_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"issue":"Suppl. 1","key":"10.1016\/j.ejogrb.2009.11.001_bib15","first-page":"77i","article-title":"Comparative effects of a four-phasic regimen of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel on haemostatic parameters","volume":"23","author":"Parke","year":"2008","journal-title":"Hum Reprod"},{"issue":"4(Suppl.)","key":"10.1016\/j.ejogrb.2009.11.001_bib16","first-page":"12S","article-title":"Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest","volume":"111","author":"Parke","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2009.11.001_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13625180902850039","article-title":"Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest","volume":"14","author":"Zeun","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.ejogrb.2009.11.001_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ejogrb.2009.11.001_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2009.11.001_bib20","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use. Journal [serial on the Internet]; 2004. Available from: http:\/\/www.who.int\/reproductive-health\/publications\/mec\/mec.pdf."},{"issue":"5","key":"10.1016\/j.ejogrb.2009.11.001_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.11.001_bib22","series-title":"The menopause","first-page":"130","article-title":"Potency of different oestrogen preparations","author":"von Schoultz","year":"1988"},{"key":"10.1016\/j.ejogrb.2009.11.001_bib23","first-page":"1","article-title":"Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects","volume":"107","author":"Helgason","year":"1982","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"issue":"1","key":"10.1016\/j.ejogrb.2009.11.001_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0038-1646528","article-title":"A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters","volume":"61","author":"Lindberg","year":"1989","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ejogrb.2009.11.001_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2004.03.004","article-title":"Effect of four oral contraceptives on hemostatic parameters","volume":"70","author":"Wiegratz","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2009.11.001_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"issue":"Suppl. 1","key":"10.1016\/j.ejogrb.2009.11.001_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13625189909085259","article-title":"The pharmacological profile of dienogest","volume":"4","author":"Oettel","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.ejogrb.2009.11.001_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ejogrb.2009.11.001_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2008.10.010","article-title":"Efficacy of a combined oral contraceptive containing 0.030mg ethinylestradiol\/2mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035mg ethinylestradiol\/2mg cyproterone acetate","volume":"79","author":"Palombo-Kinne","year":"2009","journal-title":"Contraception"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211509006538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211509006538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:22:31Z","timestamp":1759555351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211509006538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0301211509006538"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2009.11.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722757076.793503812","asserted-by":"object"}]},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): A Phase III trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2009.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}